A PVC-membrane ion-selective electrode was constructed for quantitative monitoring of gadolinium(III) ion based on 3-methyl-1H-1,2,4-triazole-5-ylhydrosufide (MTY) as an ion carrier. The electrode performance includes a Nernstian slope of 19.8 ± 0.4 mV per decade across a wide concentration range between 1.0 × 10 and 1.0 × 10 M and a detection limit of 7.3 × 10 M. The best performance was obtai...

BACKGROUND Although there is a well-documented risk of acute renal failure (ARF) with the iodinated contrast agents, intravenous gadolinium-based contrast agents are considered non-nephrotoxic and have been widely used for magnetic resonance imaging (MRI). However, debate continues regarding the safety issue of gadolinium, especially in patients with kidney failure. Therefore, we aimed to evalu...

AIMS Determination of the myocardium at risk (MaR) and final infarct size by cardiac magnetic resonance imaging (CMR) enables calculation of salvaged myocardium in acute infarction. T2-weighted imaging is performed prior to the administration of gadolinium, since gadolinium affects T2 tissue properties. This is, however, difficult in an ex vivo model since gadolinium must be administered for de...

Introduction Primovist (gadoxetic acid; Gd-EOB-DTPA)-enhanced MR imaging has been used for the diagnosis of focal hepatic lesions worldwide. However, except for spatial misregistration due to breath-hold failure, empirically 10-15% of cases suffer from so-called “ringing artifacts” during the acquisition of the arterial phase. These artifacts aggravate the detection and characterization of foca...

High-density lipoprotein (HDL) nanoparticles doped with gadolinium lipids can be used as magnetic resonance imaging diagnostic agents for atherosclerosis. In this study, HDL nanoparticles with different molar fractions of gadolinium lipids (0 < xGd-lipids < 0.33) were prepared, and the MR relaxivity values (r1 and r2) for all compositions were measured. Both r1 and r2 parameters reached a maxim...

Two of six cats receiving small-field, single-dose, brain irradiation of 35 Gy with 6 MeV photons developed brain abnormalities in the irradiated area on MR images at 6 and 8 months, respectively, after treatment. The lesions were of high intensity on T2-weighted images and did not enhance after IV administration of gadolinium-DTPA. An additional lesion in one of these cats displayed high signa...

OBJECTIVE To prevent iodinated contrast medium-induced nephrotoxicity, gadolinium has been used increasingly for magnetic resonance angiography (MRA) or conventional digital subtraction angiography (DSA) to visualize arterial anatomy in patients undergoing vascular surgery who are considered at high risk because of chronic renal insufficiency. We assessed the safety of gadolinium-based contrast...

Background Patients with hereditary tumor syndromes undergo periodical magnetic resonance imaging (MRI) screening with Gadolinium contrast. Gadolinium accumulation has recently been described in the central nervous system after repeated administrations. The prevalence and rate of accumulation in different subgroups of patients are unknown. Neither are the mechanism nor clinical impact. This may...